CALCYON Gene Variation, Schizophrenia, and Cocaine Dependence

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 125 B, Issue 1, 2004, Pages 25-30

  Luo, Xingguang ^a,b   Kranzler, Henry ^c   Lappalainen, Jaakko ^a,b   Rosenheck, Robert ^a,b   Charney, Dennis ^d   Zuo, Lingjun ^a,b   Erdos, Joseph ^a,b   Van Kammen, Daniel P ^e,f   Gelernter, Joel ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e SANOFI   (France)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Allele; CALCYON gene; Cocaine dependence; Haplotype; Schizophrenia

Indexed keywords

DOPAMINE 1 RECEPTOR;

AFRICAN AMERICAN; ARTICLE; CALCYON GENE; COCAINE DEPENDENCE; COGNITION; CONTROLLED STUDY; EUROPEAN AMERICAN; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MOTOR CONTROL; PRIORITY JOURNAL; REWARD; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

MARTES PENNANTI;

EID: 0942279750     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20092     Document Type: Article

References (47)

1. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, Hwang DR, Keilp J, Kochan L, Heertum RV, Gorman JM, Laruelle M. 2002. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22:3708-3719.
2. Angrist M, Jing S, Bolk S, Bentley K, Nallasamy S, Halushka M, Fox GM, Chakravarti A. 1998. Human GFRA1: Cloning, mapping, genomic structure, and evaluation as a candidate gene for Hirschsprung disease susceptibility. Genomics 48(3):354-362.
3. Blouin AG, Perez EL, Blouin JH. 1988. Computerized administration of the diagnostic interview schedule. Psychiatr Res 23:335-344.
4. Botstein D, White RL, Skolnick MH. 1980. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet 32:314-331.
5. Choi SJ, Mazzio E, Soliman KF. 1998. The effects of gestational cocaine exposure on pregnancy outcome, postnatal development, cognition, and locomotion in rats. Ann N Y Acad Sci 844:324-335.
6. Ciccocioppo R, Sanna PP, Weiss F. 2001. Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: Reversal by D1 antagonists. Proc Natl Acad Sci USA 98:1976-1981.
7. DeLisi LE, Craddock NJ, Detera-Wadleigh S, Foroud T, Gejman P, Kennedy JL, Lendon C, Macciardi F, McKeon P, Mynett-Johnson L, Nurnberger JI Jr, Paterson A, Schwab S, Van Broeckhoven C, Wildenauer D, Crow TJ. 2000. Update on chromosomal locations for psychiatric disorders: Report of the interim meeting of chromosome workshop chairpersons from the VIIth World Congress of Psychiatric Genetics, Monterey, California, October 14-18, 1999. Am J Med Genet 96:434-449.
8. Ewald H, Flint TJ, Jorgensen TH, Wang AG, Jensen P, Vang M, Mors O, Kruse TA. 2002. Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. Am J Med Genet 114:196-204.
9. Falk CT, Rubinstein P. 1987. Haplotype relative risks: An easy way to construct a control sample for risk calculations. Ann Hum Genet 51: 227-233.
10. Fisher SE, Francks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Crawford LR, Palmer CG, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL. 2002. A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70:1183-1196.
11. Gorodinsky A, Zimonjic DB, Popescu NC, Milbrandt J. 1997. Assignment of the GDNF family receptor alpha-1 (GFRA1) to human chromosome band 10q26 by in situ hybridization. Cytogenet Cell Genet 78(3-4):289-290.
12. Green MF. 1996. What are the functional consequences of neurocognitive deficits in schizophrenia? Am J Psychiatry 153:321-330.
13. Henry DJ, White FJ. 1995. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15:6287-6299.
14. Hummel M, Unterwald EM. 2002. D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action. J Cell Physiol 191:17-27.
15. Koh PO, Bergson C, Undie AS, Goldman-Rakic PS, Lidow MS. 2003. Receptor-interacting proteins as sites of dopamine system dysfunction in schizophrenia: Upregulation of the D1-receptor-interacting protein, calcyon, in schizophrenic patients. Arch Gen Psychiatry 60:311-319.
16. Kohler J, Rohrig D, Bathke KD, Koch MC. 1999. Evaluation of the faciosca-pulohumeral muscular dystrophy (FSHD1) phenotype in correlation to the concurrence of 4q35 and 10q26 fragments. Clin Genet 55:88-94.
17. Levinson DF, Mahtani MM, Nancarrow DJ, Brown DM, Kruglyak L, Kirby A, Hayward NK, Crowe RR, Andreasen NC, Black DW, Silverman JM, Endicott J, Sharpe L, Mohs RC, Siever LJ, Walters MK, Lennon DP, Jones HL, Nertney DA, Daly MJ, Gladis M, Mowry BJ. 1998. Genome scan of schizophrenia. Am J Psychiatry 155:741-750.
18. Lewontin RC. 1988. On measures of gametic disequilibrium. Genetics 120: 849-852.
19. Lezcano N, Mrzljak L, Eubanks S, Levenson R, Goldman-Rakic P, Bergson C. 2000. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein. Science 287:1660-1664.
20. Long JC, Williams RC, Urbanek M. 1995. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56:799-810.
21. Lukusa T, Fryns JP. 2002. Pure distal monosomy 10q26 in a patient displaying clinical features of Prader-Willi syndrome during infancy and distinct behavioural phenotype in adolescence. Genet Couns 11: 119-126.
22. Luo X, Klempan TA, Lappalainen J, Rosenheck RA, Charney DS, Erdos J, van Kammen DP, Kranzler HR, Kennedy JL, Gelernter J. NOTCH4 gene haplotype is associated with schizophrenia in African-Americans. Biol Psychiatry (in press).
23. Mitchell CA, Speed CJ, Nicholl J, Sutherland GR. 1996. Chromosomal mapping of the gene (INPP5A) encoding the 43-kDa membrane-associated inositol polyphosphate 5-phosphatase to 10q26.3 by fluorescence in situ hybridization. Genomics 31:139-140.
24. Morrow BA, Elsworth JD, Roth RH. 2002. Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res 129:217-223.
25. Ott J. 1992. Strategies for characterizing highly polymorphic markers in human gene mapping. Am J Hum Genet 51:283-290.
26. Perlstein WM, Dixit NK, Carter CS, Noll DC, Cohen JD. 2003. Prefrontal cortex dysfunction mediates deficits in working memory and prepotent responding in schizophrenia. Biol Psychiatry 53:25-38.
27. Petit P, Devriendt K, Azou M, Gewillig M, Fryns JP. 1998. Terminal deletion of chromosome 10q26: Delineation of two clinical phenotypes. Genet Couns 9:271-275.
28. 3H-SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. Eur J Pharmacol 114:235-237.
29. Rosenheck R, Cramer J, Xu W, Thomas J, Henderson W, Frisman L, Fye C, Charney D. 1997. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 337:809-815.
30. Sawaguchi T, Goldman-Rakic PS. 1991. D1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science 251:947-950.
31. Self DW, Barnhart WJ, Lehman DA, Nestler EJ. 1996. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 276:1586-1589.
32. Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W. 2002. Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61-74.
33. Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL, Kliegman R. 2002. Cognitive and motor outcomes of cocaine-exposed infants. JAMA 287:1952-1960.
34. Sinnott RS, Nader MA. 2001. Modulation of cocaine's discriminative stimulus effects by dopamine D1 agonists in rhesus monkeys. Pharmacol Biochem Behav 68:301-309.
35. Spielman RS, McGinnis RE, Ewens WJ. 1993. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-516.
36. Spitzer RL, Endicott J. 1975. Schedule for affective disorders and schizophrenia: Lifetime version. New York: New York Biometrics Research Division, New York State Psychiatric Institute.
37. Spitzer RL, Williams JBW, Gibbon M, First MB. 1992. The structured clinical interview for DSM-III-R (SCID), I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
38. Thomson G. 1995. Analysis of complex human genetic traits: An ordered-notation method and new tests for mode of inheritance. Am J Hum Genet 57:474-486.
39. Ushijima I, Carino A, Horita A. 1995. Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats. Pharmacol Biochem Behav 52:737-741.
40. Wang N, Akey JM, Zhang K, Chakraborty R, Jin L. 2002. Distribution of recombination crossovers and the origin of haplotype blocks: The interplay of population history, recombination, and mutation. Am J Hum Genet 71:1227-1234.
41. Weed MR, Woolverton WL. 1995. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275: 1367-1374.
42. Wildenauer DB, Schwab SG. 1999. Chromosome 8 and 10 workshop. Am J Med Genet 88:239-243.
43. Williams NM, Rees MI, Holmans P, Norton N, Cardno AG, Jones LA, Murphy KC, Sanders RD, McCarthy G, Gray MY, Fenton I, McGuffin P, Owen MJ. 1999. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum Mol Genet 8:1729-1739.
44. Wu KH, Yu MT, Tsai FJ, Peng CT, Tsai CH. 2002. Monosomy of chromosome 10q26 with mild psychomotor retardation: Report of one case. Acta Paediatr Taiwan 43:153-156.
45. Xu M, Hu X, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S. 1994. Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79:945-955.
46. Zelenin S, Aperia A, Diaz Heijtz R. 2002. Calcyon in the rat brain: Cloning of cDNA and expression of mRNA. J Comp Neurol 446:37-45.
47. Zhang D, Zhang L, Lou DW, Nakabeppu Y, Zhang J, Xu M. 2002. The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J Neurochem 82:1453-1464.